Lonza
Lonza is a healthcare manufacturing organization helping pharmaceutical, biotech and nutrition companies to bring their treatments to market. They help their customers to deliver new and innovative medicines that treat a wide range of diseases, allowing their patients to benefit from life-saving and life-enhancing treatments.
Latest Lonza Content
Product News
Lonza Launches New Capsule To Deliver Acid-Sensitive Active Pharmaceutical Ingredients to the Intestine
Lonza has launched an innovative new capsule solution for intestinal (enteric) drug delivery.
Product News
Genome Editing of Immune Cells
On September 20, 2022, Lonza will host a free virtual workshop on using genome editing technologies for cell and gene therapies and drug discovery.
Product News
The New Nebula® Multimode Reader from Lonza Streamlines Quantitative Endotoxin Detection
Lonza has launched the Nebula® Multimode Reader, the first multimode reader qualified for use with Lonza’s turbidimetric, chromogenic and recombinant endotoxin detection methods.
Product News
Lonza To Establish Large-Scale, Commercial Drug Product Fill & Finish Facility in Stein (CH)
Lonza today announced plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH).
Product News
Lonza Appoints Maria Soler Nunez as Head of Group Operations
Lonza today announced that its Board of Directors has appointed Maria Soler Nunez as the new Head, Group Operations.
Product
Advertisement
Select the best fit with wide donor variety of hPBMCs
Lonza is your ideal partner when you need PBMCs. We maintain an inventory of different donors to select for the best experimental fit. Reserve and Screen multiple lots to find the lot(s) that work best for you.
Product News
More Sensitive Non-Endotoxin Pyrogen Detection Now Possible
Lonza has launched the PyroCell® Monocyte Activation Test - Human Serum System (PyroCell® MAT HS System), which uses human serum instead of fetal bovine serum.
Industry Insight
Collaboration Aims To Transform the Manufacturing of Cell Therapies
Due to the complexity of the cell therapy products and patient-specific variability, product quality and consistency are significant challenges in manufacturing. In this exclusive interview, we learn more about these challenges and the ways they can be overcome.
Advertisement
